Effect of Cepharanthin and Cytochalasin D On Platelet Internalization of Anti-Glycoprotein IIb/IIIa Antibodies

References

• Phillips DR, Charo IF. GPIIb-IIIa: The responsive integral. Cell 1991; 65: 359–362
   PubMed Web of Science ®Google Scholar
• Wencel-Drake JD, Plow EF, Kunicki TJ, Woods VL, Keller DM, Ginsberg MH. Localization of internal pools of membrane glycoproteins involved in platelet adhesive responses. Am J Pathol 1986; 124: 324–334
   PubMed Web of Science ®Google Scholar
• Wencel-Drake JD. Plasma membrane GPIIb/IIIa: Evidence for a cycling receptor pool. Am J Pathol 1990; 36: 61–70
   Google Scholar
• Wencel-Drake JD, Frelinger AL, Dieter MG, Lam SC-T. Arg-Gly-Asp-dependent occupancy of GPIIb/IIIa by applag-gin: Evidence for internalization and cycling of a platelet integrin. Blood 1993; 81: 62–69
   PubMed Web of Science ®Google Scholar
• Pytela R, Pierschbacter MD, Ginsberg MH, Plow EF, Ruo-Slahti E. Platelet membrane glycoprotein Ub/IIIa: Member of a family of Arg-Gly-Asp-specific adhesion receptors. Science 1986; 231: 1559–1562
   PubMed Web of Science ®Google Scholar
• Ruoslahti E, Pierschbachcr MD. New perspectives in cell adhesion: RGD and integrins. Science 1987; 238: 491–497
   PubMed Web of Science ®Google Scholar
• Harrison P, Wilbourn B, Debili N, Vainchenkcr W, Breton-Gorius J, Lawrie AS. Uptake of plasma fibrinogen into the alpha granules of human megakaryocytes and platelets. J Clin Invest 1989; 84: 1320–1324
   PubMed Web of Science ®Google Scholar
• Handagama P, Rappolcc DA, Werb Z, Levin J, Bainton DF. Platelet alpha-granule fibrinogen, albumin and immunoglobulin G are not synthesized by rat and mouse megakaryocyte. J. Clin Invest 1990; 86: 1364–1368
   PubMed Web of Science ®Google Scholar
• Utsumi K, Miyahara M, Sugiyama K, Sasaki J. Effect of biscoclaurine alkaloid on the cell membrane related to membrane fluidity. Ada Histochem Cytochem 1976; 9: 59–68
   Web of Science ®Google Scholar
• Miyahara M, Aono K, Queseda JS, Shimono K, Baba Y, Yamashita S. Protection by cepharanthin of the mitochondrial function from damage induced by snake venom, phospholipase A2, lysolecthin and lead. Cell Struct Fund 1978; 3: 61–65
   Web of Science ®Google Scholar
• Shiraishi N, Arima T, Aono K, Inouye B, Morimoto Y, Utsumi K. Inhibition of biscoclaurine alkaloid of lipid peroxidation in biological membranes. Physiol Chem Physics 1980; 12: 299–305
   PubMedGoogle Scholar
• Aono K, Shiraishi N, Arita T, Inouye B, Nakazawa T, Utsumi K. Changes in mitochondrial function by lipid peroxidation and their inhibition by biscoclaurine alkaloid. Physiol Chem Physics 1981; 13: 137–144
   PubMedGoogle Scholar
• Nagatsuka S, Nakazawa T. Effects membrane-stabilizing agents, cholesterol and cepharanthin, on radiation-induced lipid peroxidation and permeability in liposomes. Biochem BiophysAda 1982; 691: 171–177
   Google Scholar
• Miyahara M, Okimatsu E, Mikasa H, Tcrada S, Kodama H, Utsumi K. Improvement of the anoxia-induced mitochondrial dysfunction by membrane modulation. Arch Biochem Biophys 1984; 233: 139–150
   PubMed Web of Science ®Google Scholar
• Kanaho Y, Fujii T. Effect of some amphophilic drugs on the membrane morphology and aggregation of rabbit platelets. Biochem Biopshys Res Communs 1082; 106: 513–519
   Google Scholar
• Nomura S, Yanabu M, Fukuroi T, Kido H, Kawakatsu T, Yamaguchi K. Anti-glycoprotein IIb/IIIa autoantibodies are reversibly internalized into platelets in idiopathic (autoimmune) thrombocytopenic purpura. Autoimmunity 1992; 13: 133–140
   PubMed Web of Science ®Google Scholar
• Nomura S, Nagata H, Oda K, Kokawa T, Yasunaga K. Effects of EDTA on the membrane glycoproteins IIb-IIIa complex –analysis using flow cytometry –. Thromh Res 1987; 47: 47–58
   PubMed Web of Science ®Google Scholar
• Nomura S, Kokawa T. Recent advance on analysis of antiplatelet antibody –special reference to application of flow cytometry. Automation and New Technology in the Clinical Laboratory, K. Okuda. Blackwell Scientific Publications, Oxford 1990; 287–294
   Google Scholar
• Woods VL, Oh EH, Mason D, McMillan R. Autoantibodies against the platelet glycoprotein Ilb/IIIa complex in patients with chronic ITP. Blood 1984; 63: 368–375
   PubMed Web of Science ®Google Scholar
• McMillan R, Tani P, Millard F, Bcrchtold P, Rcnshaw L, Woods VL. Platelet-associated and plasma anti-glycoprotein autoantibodies in chronic ITP. Blood 1987; 70: 1040–1045
   PubMed Web of Science ®Google Scholar
• Nomura S, Yanabu M, Soga T, Kido H, Fukuroi T, Yamaguchi K. Analysis of idiopathic thrombocytopenic purpura patients with antiglycoprotein IIb/IIIa or Ib autoantibodies. Acta Haematol 1991; 86: 25–30
   PubMed Web of Science ®Google Scholar
• Fujisawa K, Tani P, McMillan R. Platelet-associated antibody to glycoprotein Ilb/IIIa from chronic immune thrombocytopenic purpura patients often binds to divalent cation-dependent antigens. Blood 1993; 81: 1284–1289
   PubMed Web of Science ®Google Scholar
• Casclla JF, Flanagan MD, Lin S. Cytochalasin D inhibits actin polymerization and induces depolymerization of actin filaments formed during pletelet shape change. Nature 1981; 293: 302
   PubMedGoogle Scholar
• Olorundare OE, Simmons SR, Albrecht RM. Cytochalasin D and E: effects on fibrinogen receptor movement and cytoskclctal reorganization in fully spread, surfaceactivated platelets: a correlative light and electron microscopic investigation. Blood 1992; 79: 99–109
   PubMed Web of Science ®Google Scholar
• Santoso S, Zimmermann U, Neppert J, Mullcr-Eckhardt C. Receptor patching and capping of platelet membranes induced by monoclonal antibodies. Blood 1986; 67: 343–349
   PubMed Web of Science ®Google Scholar
• Morgenstern E, Ruf A, Patscheke H. Transport of antiglycoprotein IIb/IIIa antibodies into the alpha-granules of unstimulated human blood platelets. Thromb Haemoslas 1992; 67: 121–125
   PubMed Web of Science ®Google Scholar
• Sugiyama T, Okuma M, Ushikubi F, Sensaki S, Kanaji K, Uchino H. A novel platelet aggregating factor found in a patient with defective collagen-induced platelet aggregation and autoimmune thrombocytopenia. Blood 1987; 69: 1712–1720
   PubMed Web of Science ®Google Scholar
• Yanabu M, Nomura S, Fukuroi T, Soga T, Rondo K, Sone N. Synergistic action in platelet activation induced by an antiplatelet autoantibody in ITP. Br J Haematol 1991; 78: 87–93
   PubMedGoogle Scholar
• Yanabu M, Nomura S, Fukuroi T, Suzuki M, Kawakatsu T, Kido H. Platelet activation induced by an antiplatelet autoantibody against CD9 antigen and its inhibition by another autoantibody in immune thrombocytopenic purpura. Br J Haematol 1993; 84: 694–701
   PubMed Web of Science ®Google Scholar
• Kobayashi M, Katayama T, Ochiai S, Yoshida M, Kaito K, Matsuoka H. High-dose cepharanthin therapy for idiopathic thrombocytopenic purpura. Rinsho-Ketsucki 1992; 33: 405–407
   PubMedGoogle Scholar
• Nakayama S, Matsushita A, Ichiba S, Nagai K. Clinical evaluation of cepharanthin for chronic idiopathic thrombocytopenic purpura. Rinsho-Ketsueki 1992; 33: 408–409
   PubMedGoogle Scholar
• Anderson GP, Anderson CL. Signal transduction by the platelet Fc receptor. Blood 1990; 76: 1165–1172
   PubMed Web of Science ®Google Scholar